Jim Liang

C-Level strategy and corporate development executive with in-depth experience creating and executing growth strategies.

📍 Ponte Vedra Beach, Florida, United States🔄 Updated September 2026💼 5 investments📅 12 years investing🗓 Last invested May 2021𝕏 @upgrade_to_unlock
Angel investor🌍 United States
5
Total investments
2
Early stage
0
Mid stage
0
Late stage
12y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Mar 2019
Acclivity’s secure, cloud-based, connected care platform leverages analytics, Artificial Intelligence, machine learning, and workflow management tools to analyze patient populations based on health history, demographics, and behavioral indicators to predict prognoses for patients who could benefit from a more appropriate plan of care. The platform is HITRUST CSF certified and been approved to collaborate with the Centers for Medicare and Medicaid Services (CMS) on their various value based care programs. The Acclivity platform and its reporting features have enabled healthcare organizations to reduce hospital admissions, ED utilization, and unnecessary spending; realize per member per month savings for patients guided by its solutions; increase hospice length of stay significantly; and generate increases in revenue.
Board Member
Jan 2019
Vincere Biosciences is dedicated to conquering age-related diseases through the development of small molecule therapeutics empowered by a suite of computational tools alongside traditional biology and drug discovery expertise. Our innovative approach focuses on developing small molecules that enhance the removal of damaged mitochondria by modulating mitochondrial quality control mechanisms, such as mitophagy. With the potential to be groundbreaking, these small molecules could become the world's first-ever medicines capable of slowing down or even halting the progression of debilitating conditions like Parkinson's disease and other age-related diseases. By doing so, we aim to transform the lives of hundreds of millions of patients across the globe. We welcome you to follow our page for more content about our company, our dedicated team, and the science that drives what we do.
Experience · 7 entries
All (7)
Investments (5)
Board (5)
2021
Board Member
May 2021
Landstar stands for safe, secure and reliable transportation services delivered by our unique network of small business owners. Independent agents and capacity providers operating under the Landstar umbrella enjoy the strength and support of one of the industry’s most stable and successful companies. Our network of independent entrepreneurs provide customers with personalized service at the local level with the global reach and resources of a multi-billion dollar, Fortune 500 company. With 1,100 agents, 10,300+ leased owner-operators, 18,500+ trailers and trailing equipment, and 97,000+ other approved capacity providers, we have a solution to your transportation challenge. To fully understand the scope of expertise the Landstar network can provide, visit https://www.landstar.com/ or call 877-696-4507 to request more information on any service. For corporate employment opportunities: https://www.landstar.com/corporate-information/careers/ For agent pre-qualification: https://www.landstar.com/agent-pre-qualification For owner-operators: https://leasetolandstar.com/ Follow us on Facebook: https://www.facebook.com/LandstarSystem
2019
Board Member
Mar 2019
Acclivity’s secure, cloud-based, connected care platform leverages analytics, Artificial Intelligence, machine learning, and workflow management tools to analyze patient populations based on health history, demographics, and behavioral indicators to predict prognoses for patients who could benefit from a more appropriate plan of care. The platform is HITRUST CSF certified and been approved to collaborate with the Centers for Medicare and Medicaid Services (CMS) on their various value based care programs. The Acclivity platform and its reporting features have enabled healthcare organizations to reduce hospital admissions, ED utilization, and unnecessary spending; realize per member per month savings for patients guided by its solutions; increase hospice length of stay significantly; and generate increases in revenue.
Board Member
Jan 2019
Vincere Biosciences is dedicated to conquering age-related diseases through the development of small molecule therapeutics empowered by a suite of computational tools alongside traditional biology and drug discovery expertise. Our innovative approach focuses on developing small molecules that enhance the removal of damaged mitochondria by modulating mitochondrial quality control mechanisms, such as mitophagy. With the potential to be groundbreaking, these small molecules could become the world's first-ever medicines capable of slowing down or even halting the progression of debilitating conditions like Parkinson's disease and other age-related diseases. By doing so, we aim to transform the lives of hundreds of millions of patients across the globe. We welcome you to follow our page for more content about our company, our dedicated team, and the science that drives what we do.
2015
The Data Council
Board Member
Aug 2015
2014
Board Member
Jun 2014
Vesta is an end-to-end transaction guarantee platform for online purchases. We use machine learning backed by 25 years of transactional data to increase approvals of legitimate sales for our customers, while eliminating chargebacks and other forms of digital fraud. We drive the true cost of fraud to zero and transfer 100% of the liability for fraud, including chargeback processing, so customers can focus on increasing sales.
Show all 7 entries ↓
Investment activity
2014–2021 · 5 investments
20141201512019220211
Recent (last 2 years)Earlier